Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025
Maravai LifeSciences (NASDAQ: MRVI), a global provider of life science reagents and services, has scheduled its first quarter 2025 financial results announcement for Monday, May 12, 2025, after market close. The company will host a conference call and webcast at 2:00 p.m. PT/ 5:00 p.m. ET on the same day.
Participants can join the conference call by dialing (800) 343-4849 or (203) 518-9848 and referencing Conference ID MARAVAI. The event will also be accessible via webcast through the "Investors" section of Maravai's website.
Maravai LifeSciences (NASDAQ: MRVI), fornitore globale di reagenti e servizi per le scienze della vita, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per lunedì 12 maggio 2025, dopo la chiusura del mercato. La società terrà una conference call e una trasmissione in webcast alle 14:00 PT / 17:00 ET dello stesso giorno.
I partecipanti potranno unirsi alla conference call chiamando il numero (800) 343-4849 o (203) 518-9848 e indicando il Conference ID MARAVAI. L’evento sarà inoltre disponibile in webcast nella sezione "Investitori" del sito web di Maravai.
Maravai LifeSciences (NASDAQ: MRVI), proveedor global de reactivos y servicios para ciencias de la vida, ha programado el anuncio de resultados financieros del primer trimestre de 2025 para el lunes 12 de mayo de 2025, después del cierre del mercado. La compañía realizará una conferencia telefónica y una transmisión por webcast a las 2:00 p.m. PT / 5:00 p.m. ET ese mismo día.
Los participantes pueden unirse a la conferencia llamando al (800) 343-4849 o al (203) 518-9848 y mencionando el ID de conferencia MARAVAI. El evento también estará disponible vía webcast en la sección "Inversores" del sitio web de Maravai.
Maravai LifeSciences (NASDAQ: MRVI)는 생명 과학 시약 및 서비스를 제공하는 글로벌 기업으로, 2025년 1분기 재무 실적 발표를 2025년 5월 12일 월요일 시장 마감 후에 예정하고 있습니다. 같은 날 오후 2시 PT / 오후 5시 ET에 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다.
참석자는 (800) 343-4849 또는 (203) 518-9848로 전화하여 Conference ID MARAVAI를 참조하여 컨퍼런스 콜에 참여할 수 있습니다. 이 행사는 Maravai 웹사이트의 "Investors" 섹션을 통해 웹캐스트로도 시청할 수 있습니다.
Maravai LifeSciences (NASDAQ : MRVI), fournisseur mondial de réactifs et services pour les sciences de la vie, a programmé l'annonce des résultats financiers du premier trimestre 2025 pour le lundi 12 mai 2025, après la clôture du marché. La société organisera une conférence téléphonique et une webdiffusion à 14h00 PT / 17h00 ET le même jour.
Les participants peuvent rejoindre la conférence téléphonique en composant le (800) 343-4849 ou le (203) 518-9848 et en mentionnant l’ID de conférence MARAVAI. L’événement sera également accessible en webdiffusion via la section « Investisseurs » du site web de Maravai.
Maravai LifeSciences (NASDAQ: MRVI), ein globaler Anbieter von Reagenzien und Dienstleistungen im Bereich der Lebenswissenschaften, hat die Veröffentlichung der Finanzergebnisse für das erste Quartal 2025 für Montag, den 12. Mai 2025 nach Börsenschluss geplant. Das Unternehmen wird am selben Tag eine Telefonkonferenz und einen Webcast um 14:00 Uhr PT / 17:00 Uhr ET abhalten.
Teilnehmer können der Telefonkonferenz beitreten, indem sie (800) 343-4849 oder (203) 518-9848 anrufen und die Konferenz-ID MARAVAI angeben. Die Veranstaltung ist außerdem per Webcast im Bereich "Investoren" auf der Website von Maravai zugänglich.
- None.
- None.
SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2025 financial and operating results after the market close on Monday, May 12, 2025, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.
To participate in the conference call by telephone, dial (800) 343-4849 or (203) 518-9848 and reference Maravai LifeSciences, Conference ID MARAVAI. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at https://investors.maravai.com.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.
Contact Information: Deb Hart Maravai LifeSciences + 1 858-988-5917 ir@maravai.com
FAQ
When will Maravai LifeSciences (MRVI) report Q1 2025 earnings?
What time is Maravai LifeSciences (MRVI) Q1 2025 earnings call?
How can I join Maravai LifeSciences (MRVI) Q1 2025 earnings call?
Where can I access the webcast of Maravai LifeSciences (MRVI) Q1 2025 earnings?
